Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clover Biotech Research Profile - Seeking Alpha Blogger
53 Followers
Clover Biotech Research Seeking Alpha
Financial Blogger
Success Rate
111 out of 229 ratings made a profit
Average Return
+1.50%
Average return per rating
Time Frame
Compare to
Copying Clover Biotech Research's trades since 2017 and holding each position for 1 Year would result in 48.47% of your transactions generating a profit, with an average return of 1.5% per rating.
Stock Rating Distribution
76.89% Bullish
13.26% Bearish
9.85% Neutral
Distribution of Clover Biotech Research's ratings
Additional Information
Main Sector:General
Geo Coverage:
US Market
Canadian Market
US MarketCanadian MarketBest Rating
The most profitable rating made by Clover Biotech Research
Clover Biotech Research's Stock Coverage
Synergy Pharmaceuticals Inc
Nov 17, 2017
Bullish
2Ratings
-81.85%
Aurinia Pharmaceuticals
Nov 24, 2017
Bullish
1Ratings
+2.60%
Histogen
Dec 13, 2017
Bullish
1Ratings
-64.80%
Immune Design
May 11, 2018
Bullish
2Ratings
-55.00%
CytomX Therapeutics
May 20, 2018
Bullish
1Ratings
-55.90%
Joint
Jun 06, 2018
Bullish
1Ratings
+119.50%
Qualigen Therapeutics
Jun 06, 2018
Bearish
1Ratings
+74.50%
HTG Molecular Diagnostics
Jun 11, 2018
Bullish
1Ratings
-48.00%
Larimar Therapeutics
Jun 25, 2018
Bullish
2Ratings
-83.10%
Aimmune Therapeutics
Jul 22, 2018
Bullish
1Ratings
-36.40%
List of latest recommendations made by Clover Biotech Research. Click to expand and see Clover Biotech Research's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.